Class IIOngoingD-0224-2025
Drug recall · February 19, 2025
Irbesartan Tablets USP recall
Why: Out of Specification for Dissolution
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Irbesartan Tablets USP, 300 mg, 50 Tablets (5 x 10) Unit Dose per carton, Manufactured for: AvKARE, Pulaski, TN 38478. NDC 50268-442-15
- Lots / codes
Lot 45279, Exp 03/31/2025
- Quantity
- 341 cartons
- Company
- AvKARE, Pulaski, TN
- Distribution
- Nationwide in the USA
- Initiated
- January 21, 2025 · Voluntary: Firm initiated
- Classified
- February 11, 2025
- Reported
- February 19, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Irbesartan
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.